HALOBETASOL for Psoriatic arthropathy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where HALOBETASOL was used for Psoriatic arthropathy.
Most Reported Side Effects for HALOBETASOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 207 | 49.5% | 0 | 6 |
| Psoriasis | 85 | 20.3% | 0 | 1 |
| Product use in unapproved indication | 59 | 14.1% | 0 | 0 |
| Therapeutic product effect incomplete | 43 | 10.3% | 0 | 0 |
| Treatment failure | 41 | 9.8% | 0 | 0 |
| Pruritus | 34 | 8.1% | 0 | 1 |
| Condition aggravated | 29 | 6.9% | 0 | 0 |
| Rash | 28 | 6.7% | 0 | 2 |
| Skin exfoliation | 28 | 6.7% | 0 | 2 |
| Off label use | 27 | 6.5% | 0 | 0 |
| Erythema | 26 | 6.2% | 0 | 2 |
| Arthralgia | 24 | 5.7% | 0 | 1 |
| Cough | 20 | 4.8% | 0 | 0 |
| Skin lesion | 20 | 4.8% | 0 | 1 |
| Pain in extremity | 19 | 4.6% | 0 | 5 |
Other Indications for HALOBETASOL
Psoriasis (209)
Product used for unknown indication (96)
Pruritus (13)
Rash (11)
Eczema (7)
Hidradenitis (7)
Lichen sclerosus (7)
Dyshidrotic eczema (6)
Dermatitis atopic (5)
Lichenoid keratosis (5)
Other Drugs Used for Psoriatic arthropathy
ADALIMUMAB (47,183)
ETANERCEPT (39,876)
SECUKINUMAB (38,507)
APREMILAST (33,990)
CERTOLIZUMAB PEGOL (10,537)
METHOTREXATE (6,997)
RISANKIZUMAB-RZAA (6,970)
TOFACITINIB (6,384)
USTEKINUMAB (5,909)
IXEKIZUMAB (5,798)